Quarry LP Travere Therapeutics, Inc. Transaction History
Quarry LP
- $456 Billion
- Q3 2025
A detailed history of Quarry LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Quarry LP holds 14,960 shares of TVTX stock, worth $516,120. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,960
Previous 7,000
113.71%
Holding current value
$516,120
Previous $104 Million
245.12%
% of portfolio
0.08%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding TVTX
# of Institutions
269Shares Held
100MCall Options Held
2.36MPut Options Held
955K-
Janus Henderson Group PLC London, X010.6MShares$366 Million0.12% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$264 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.72MShares$232 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.61MShares$228 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C34.98MShares$172 Million0.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $2.21B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...